In a recently published study, we documented our experience using platelet-rich plasma (PRP) and concentrated bone marrow mononucleated cells (BMMNCs) for the treatment of musculoskeletal injuries (ligament and tendon overuse injuries) in competition horses refractory to other therapies [1]. We evaluated number of cells and presence of growth factors (GFs) injected, and performed follow-ups on horses weekly, up to one year. The results of our study showed a marked improvement in the degree of lameness, with 84.6% of horses returning to competition, and a direct correlation between number of platelets injected and clinical outcome.
Torricelli, P., Filardo, G., Kon, E., Fini, M. (2011). Reply to comments of Carmona et al. to the article: Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. INTERNATIONAL ORTHOPAEDICS, 35(11), 1747-1748 [10.1007/s00264-011-1312-9].
Reply to comments of Carmona et al. to the article: Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses
FILARDO, GIUSEPPE;KON, ELIZAVETA;FINI, MILENA
2011
Abstract
In a recently published study, we documented our experience using platelet-rich plasma (PRP) and concentrated bone marrow mononucleated cells (BMMNCs) for the treatment of musculoskeletal injuries (ligament and tendon overuse injuries) in competition horses refractory to other therapies [1]. We evaluated number of cells and presence of growth factors (GFs) injected, and performed follow-ups on horses weekly, up to one year. The results of our study showed a marked improvement in the degree of lameness, with 84.6% of horses returning to competition, and a direct correlation between number of platelets injected and clinical outcome.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
